Resources Contact Us Home
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Image Number 17 for United States Patent #8129185.

Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4.sup.+CD25.sup.+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

  Recently Added Patents
Method of predicting a motion vector for a current block in a current picture
Methods for selective reverse mask planarization and interconnect structures formed thereby
Aluminum galvanic cell
Compact multi-functional scanning apparatus with retractable flatbed scanner
Method of forming an isolation structure
Surface modification
Water slide
  Randomly Featured Patents
Mold for nano-imprinting and method of manufacturing the same
Method for making investment casting molds for casting of superalloys
Integrated circuit and assembly therewith
Icon for a portion of a display screen
Carrier-lifetime-controlled selective etching process for semiconductors using photochemical etching
Fish gaff
Fuel filter of a motor vehicle
Electrochemical sensor
SRDF assist
Pile sock